A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B®, among vaccine naïve and vaccine non-responder dialysis patients

被引：0
|
作者：
E. Elhanan
M. Boaz
I. Schwartz
D. Schwartz
G. Chernin
H. Soetendorp
A Gal Oz
A. Agbaria
T. Weinstein
机构：
[1] Tel Aviv University,Nephrology Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine
[2] Epidemiology and Research Unit,undefined
[3] E. Wolfson Medical Center,undefined
[4] Ariel University,undefined
来源：
Clinical and Experimental Nephrology | 2018年 / 22卷
关键词：
Dialysis; HBV vaccine; Sci-B-Vac; Engerix;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 158
页数：7
相关论文
共 50 条
  • [1] A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix BA®, among vaccine na⟨ve and vaccine non-responder dialysis patients
    Elhanan, E.
    Boaz, M.
    Schwartz, I.
    Schwartz, D.
    Chernin, G.
    Soetendorp, H.
    Oz, A. Gal
    Agbaria, A.
    Weinstein, T.
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (01) : 151 - 158
  • [2] Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial
    Diaz-Mitoma, Francisco
    Popovic, Vlad
    Spaans, Johanna N.
    [J]. VACCINE, 2021, 39 (29) : 3892 - 3899
  • [3] The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population
    Jacques, P
    Moens, G
    Desombere, I
    Dewijngaert, J
    Leroux-Roels, G
    Wettendorff, M
    Thoelen, S
    [J]. VACCINE, 2002, 20 (31-32) : 3644 - 3649
  • [4] immunogenicity of Sci-B-Vac (a Third-Generation Hepatitis B Vaccine) in HIV-Positive Adults
    Alon, Danny
    Stein, Gideon Y.
    Hadas-Golan, Vered
    Tau, Luba
    Brosh, Tal
    Turner, Dan
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (03): : 143 - 146
  • [5] Comparison Between Sci-B-Vac™ (Third Generation Vaccine) and Engerix-B Vaccines for Hepatitis B Virus in Patients With Inflammatory Bowel Diseases Treated With Immunosuppressive Medications. Randomized Control Trial
    Etzion, Ohad
    Novack, Victor
    Perl, Yael
    Abel, Olga
    Schwartz, Doron
    Abufreha, Naim
    Munteanu, Daniela
    Ben-Yakov, Gil S.
    Fich, Alexander
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S269 - S269
  • [6] A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine
    Dupont, Juan
    Altclas, Javier
    Lepetic, Alejandro
    Lombardo, Monica
    Vazquez, Vicente
    Salgueira, Claudia
    Seigelchifer, Mauricio
    Arndtz, Nathaly
    Antunez, Ernesto
    von Eschen, Kenneth
    Janowicz, Zbigniew
    [J]. VACCINE, 2006, 24 (49-50) : 7167 - 7174
  • [7] Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
    Rendi-Wagner, P
    Shouval, D
    Genton, B
    Lurie, Y
    Rümke, H
    Boland, G
    Cerny, A
    Heim, M
    Bach, D
    Schroeder, M
    Kollaritsch, H
    [J]. VACCINE, 2006, 24 (15) : 2781 - 2789
  • [8] The evaluation of Tetanus-diphtheria (Td) vaccine impacts on immune response to hepatitis B (HB) vaccine in non-responder dialysis patients
    Shahidi, Shahrzad
    Ghareghani, Nasrin Namdari
    Mortazavi, Mojgan
    Sadeghi, Somaye
    Adeli, Reza
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (05): : 598 - 604
  • [9] Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac
    Safadi, Rifaat
    Khoury, Tawfik
    Saed, Nizar
    Hakim, Marwan
    Jamalia, Jeryes
    Nijim, Yousef
    Farah, Nicola
    Nuser, Tawfik
    Natur, Nidaa
    Mahamid, Mahmud
    Amer, Johnny
    Roppert, Pia L.
    Gerlich, Wolfram H.
    Glebe, Dieter
    [J]. VACCINES, 2021, 9 (04)
  • [10] Higher proportion of responders with hepatitis B antibody levels=100 miu/ml with the trivalent HepB vaccine, Sci-B-Vac, compared to Engerix-B: results from the phase 3 double-blind, randomized study comparing immunogenicity and safety (PROTECT)
    Vesikari, Timo
    Langley, Joanne
    Segall, Nathan
    Ward, Brian
    Cooper, Curtis
    Poliquin, Guillaume
    Gantt, Soren
    Smith, Bruce
    Van Damme, Pierre
    Leroux-Roels, Isabel
    Leroux-Roels, Geert
    Machluf, Nathalie
    Spaans, Johanna
    Yassin-Rajkumar, Bebi
    Anderson, David
    Popovic, Vlad
    Diaz-Mitoma, Francisco
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S579 - S579
12345